Abstract
Three very low birth weight infants, treated with frusemide for broncho-pulmonary dysplasia are described. They all developed medullary nephrocalcinosis identifiable by real time ultrasound. The sonographic findings of diffuse medullary hyper-echogenicity appears to be specific for nephrocalcinosis.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Bronchopulmonary Dysplasia / drug therapy
-
Female
-
Furosemide / adverse effects*
-
Humans
-
Infant, Low Birth Weight*
-
Infant, Newborn
-
Male
-
Nephrocalcinosis / chemically induced*
-
Nephrocalcinosis / diagnosis
-
Ultrasonography